Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,205.1
16.6 (0.52%)

 

  • STI Straits Times Index
    3,205.1
    16.6 (0.52%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,588.1
    -3.5 (-0.22%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,126.9
    109.4 (0.42%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,582.6
    -12.2 (-0.34%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,804.8
    96.3 (0.34%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,643.7
    10.8 (0.16%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,256.9M
  • Value: 811.0M
  • Rise: 183
  • Fall: 150
  • Unch: 418

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Hatten Land0.068-0.003
King Wan0.055-0.002
Boldtek0.084+0.020
Sembcorp Marine0.079-0.001
Sinjia Land0.086+0.007
Raffles Edu0.071+0.010
Rex Intl0.345-0.005
ThaiBev0.715+0.010
Shen Yao0.002-0.001
No Signboard0.052-

World Indices

World Indices
Name Last Change
Nasdaq 15,090.2 -125.5
HSI 26,126.9 +109.4
HSCEI 9,356.9 +83.3
Jakarta 6,643.7 +10.8
Nikkei 225 28,804.8 +96.3
SSE Comp 3,582.6 -12.2
Shanghai A 3,754.7 -12.7
Shanghai B 275.7 -1.8
KOSPI 3,006.2 -1.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

NEUBASE THERAPEUTICS INC NEUBASE THERAPEUTICS
Updated on 22 Oct 2021 (End of trading day)
Last (USD): 4.040 Change: -0.140 High: 4.220 Remarks: -
Change (%): -3.35 Low: 3.980
Open 4.220 Yesterday's Close 4.18
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 127,361 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.53136 Trailing EPS (USD) e -0.70153 NAV (USD) b 1.8423
PE a - Trailing PE f - Price / NAV b 2.1929
Dividend (USD) d - Cash In Hand (USD) g 1.7985 Issued & Paid-up Shares c 32,716,800
Dividend Yield (%) d - Price / Cash In Hand g 2.246 Treasury Shares h -
Market Cap (M) 132.176 Enterprise Value (M) 79.806
Piotroski F Score 2 Exchange Code NBSE Par Value ( $ ) n.a.
52 Weeks Volatility (%) 69.70 Free Float (%) 95.8
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 14 May 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 15 Jul 2019.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference NEUBASE THERAPEUTICS INC NASDAQ 132.176 - - 2.1929 -
Industry Pharmaceuticals: Major NASDAQ 2,327.762 86.239 91.614 3.3596 0.026
Local Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 191,442.103 59.901 50.767 12.2124 1.879
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 126,144.845 8.986 18.216 1.6821 2.712
Local Peer ROYALTY PHARMA PLC NASDAQ 22,768.950 23.352 23.436 3.9711 0.511
Local Peer VIATRIS INC NASDAQ 16,857.503 - - 0.7949 -
Local Peer REPLIGEN CORP NASDAQ 15,115.981 252.243 151.261 9.4294 -
Local Peer ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS NASDAQ 8,210.377 - - 10.0705 -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 7,681.419 - - 22.5978 -
Local Peer CUREVAC NV NASDAQ 7,184.368 - - - -
Local Peer CEREVEL THERAPEUTICS HLDGS INC NASDAQ 5,844.056 - - 19.8856 -
Local Peer ALLAKOS INC NASDAQ 5,840.261 - - 10.2284 -
Local Peer HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS NASDAQ 5,561.646 - - 5.6475 -
Local Peer I MAB SPON ADS EACH REP 2.3 ORD SHS NASDAQ 5,189.588 76.064 76.064 6.0313 -
Other Local Peers KARUNA THERAPEUTICS INC (NASDAQ), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), IMMUNITYBIO INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), ERASCA INC (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), GENERATION BIO CO (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), PROCAPS GROUP S A (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), ICOSAVAX INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), PRAXIS PRECISION MEDICINES INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), KRONOS BIO INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), TENAYA THERAPEUTICS INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), PETIQ INC (NASDAQ), ANNEXON INC (NASDAQ), GH RESEARCH PLC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), POINT BIOPHARMA GLOBAL INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), VERU INC (NASDAQ), BEYONDSPRING INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), GRITSTONE BIO INC (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), NRX PHARMACEUTICALS INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), PHARVARIS NV (NASDAQ), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), WEREWOLF THERAPEUTICS INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), EVOLUS INC (NASDAQ), AC IMMUNE SA (NASDAQ), PYXIS ONCOLOGY INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), MINK THERAPEUTICS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), PROVENTION BIO INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), CLENE INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), 89BIO INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), BIOMEA FUSION INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), NEXIMMUNE INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), ATHENEX INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), DURECT CORP (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), ANGION BIOMEDICA CORP (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), VINCERX PHARMA INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), IMMUNIC INC (NASDAQ), OBSEVA SA (NASDAQ), IMPEL NEUROPHARMA INC (NASDAQ), TRICIDA INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), MUSTANG BIO INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), ALZAMEND NEURO INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), EYENOVIA INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), POLYPID LTD (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), NOVAN INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), GENPREX INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), MEDIWOUND LTD (NASDAQ), YUMANITY THERAPEUTICS INC (NASDAQ), IMARA INC (NASDAQ), CLARUS THERAPEUTICS HLDGS INC (NASDAQ), PROPHASE LABS INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), GALECTO INC (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), MANNATECH INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), GRAYBUG VISION INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), ABVC BIOPHARMA INC (NASDAQ), SYNAPTOGENIX INC (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), UNIVERSE PHARMACEUTICALS INC (NASDAQ), VIRPAX PHARMA INC (NASDAQ), RENOVORX INC (NASDAQ), ACURX PHARMACEUTICALS INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), BONE BIOLOGICS CORP (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), BAUDAX BIO INC (NASDAQ), SEQLL INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), VIRIOS THERAPEUTICS INC (NASDAQ), XORTX THERAPEUTICS INC (NASDAQ), DERMATA THERAPEUTICS INC (NASDAQ), PASITHEA THERAPEUTICS CORP (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), NLS PHARMACEUTICS LTD (NASDAQ), PANBELA THERAPEUTICS INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), PAINREFORM LTD (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), PETROS PHARMACEUTICALS INC (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 430,989.626 29.291 24.105 - 2.431
Global Peer PFIZER INC NYSE 241,984.740 25.165 18.293 3.4548 3.520
Global Peer ELI LILLY AND COMPANY NYSE 233,166.619 37.646 38.409 36.1813 1.214
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 206,730.946 25.611 23.011 3.8254 2.270
Global Peer MERCK & CO INC NYSE 205,420.676 29.068 36.873 6.1699 3.055
Global Peer ABBVIE INC NYSE 192,870.025 42.333 29.272 15.3448 4.430
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 187,909.086 29.161 26.395 17.9730 1.269
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 127,993.536 - - 3.4773 3.226
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 100,056.150 13.572 16.869 4.7102 5.203
Global Peer WUXI APPTEC CO LTD HKEx 498,188.584 150.103 107.580 11.2848 0.209
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), HANSOH PHARMACEUTICAL GROUP CO LTD (HKEx), INNOVENT BIOLOGICS INC (HKEx), CANSINO BIOLOGICS INC (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), ORGANON & CO (NYSE), SINOPHARM GROUP CO. LTD. (HKEx), REMEGEN CO LTD (HKEx), HYGEIA HEALTHCARE HLDGS CO LTD (HKEx), HUTCHMED (CHINA) LIMITED (HKEx), SHANGHAI PHARMACEUTICALS HOLDING CO (HKEx), AKESO INC (HKEx), SHANGHAI JUNSHI BIOSCIENCES CO LTD (HKEx), CHINA MEDICAL SYSTEM HLDGS LTD (HKEx), GUANGZHOU BAIYUNSHAN PHARMACEUTICAL (HKEx), INNOCARE PHARMA LTD (HKEx), CHINA RESOURCES PHARMACEUTICAL GR (HKEx), CARSGEN THERAPEUTICS HLDGS LTD (HKEx), CHINA GRAND PHARMACEUTICAL & HEALTH (HKEx), SIMCERE PHARMACEUTICAL GRP LTD (HKEx), EMERGENT BIOSOLUTIONS INC (NYSE), CHINA TRADITIONAL CHINESE MED HLDGS (HKEx), ADC THERAPEUTICS SA (NYSE), EVEREST MEDICINES LTD (HKEx), SHANGHAI HENLIUS BIOTECH INC (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), SHENZHEN HEPALINK PHARMACEUTICAL (HKEx), SSY GROUP LIMITED (HKEx), CSTONE PHARMACEUTICALS (HKEx), OCUMENSION THERAPEUTICS (HKEx), UNITED LABORATORIES INTL HLDGS LTD (HKEx), BEIJING TONG REN TANG CHINESE MEDIC (HKEx), IMMUNOTECH BIOPHARM LTD (HKEx), ZYMEWORKS INC (NYSE), ABBISKO CAYMAN LTD (HKEx), BROOKLYN IMMUNO THERAPEUTICS INC (NYSE American), Kimia Farma Tbk. (IDX), SCICLONE PHARMACEUTICALS (HLDGS) LT (HKEx), CK LIFE SCIENCES INTL HLDG (HKEx), ANTENGENE CORP LTD (HKEx), CHINA SHINEWAY PHARMACEUTICAL GR (HKEx), TRANSCENTA HOLDING LTD (HKEx), HUA MEDICINE (HKEx), ZHAOKE OPHTHALMOLOGY LTD (HKEx), Soho Global Health Tbk. (IDX), IGBB (Bursa), RACE ONCOLOGY LTD (ASX), PYC THERAPEUTICS LIMITED (ASX), STARPHARMA HOLDINGS LIMITED (ASX), DAWNRAYS PHARMACEUTICAL HLDGS (HKEx), TOT BIOPHARM INTL CO LTD (HKEx), CYBIN INC (NYSE American), AFT PHARMACEUTICALS LTD (ASX), BSTEAD (Bursa), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), FUSEN PHARMACEUTICAL CO LTD (HKEx), PHARMA (Bursa), ANNOVIS BIO INC (NYSE American), IP (SET), CHINA BIOTECH SERVICES HLDGS LTD (HKEx), IX Biopharma (SGX), ZHONGZHI PHARMACEUTICAL HLDGS LTD (HKEx), RECCE PHARMACEUTICALS LTD (ASX), NOXOPHARM LTD (ASX), Merck Tbk. (IDX), LANNETT CO INC (NYSE),